Abstract
The mechanisms that regulate the TH9 subset of helper T cells and diseases mediated by TH9 cells remain poorly defined. Here we found that the costimulatory receptor OX40 was a powerful inducer of TH9 cells in vitro and TH9 cell–dependent airway inflammation in vivo. In polarizing conditions based on transforming growth factor-β (TGF-β), ligation of OX40 inhibited the production of induced regulatory T cells and the TH17 subset of helper T cells and diverted CD4+Foxp3− T cells to a TH9 phenotype. Mechanistically, OX40 activated the ubiquitin ligase TRAF6, which triggered induction of the kinase NIK in CD4+ T cells and the noncanonical transcription factor NF-κB pathway; this subsequently led to the generation of TH9 cells. Thus, our study identifies a previously unknown mechanism for the induction of TH9 cells and may have important clinical implications in allergic inflammation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Janeway, C.A. & Bottomly, K. Signals and signs for lymphocyte responses. Cell 76, 275–285 (1994).
Li, X.C., Rothstein, D.M. & Sayegh, M.H. Costimulatory pathways in transplantation: challenges and new developments. Immunol. Rev. 229, 271–293 (2009).
Dong, C. Diversification of T helper cell lineages: finding the family root of IL-17-producing cells. Nat. Rev. Immunol. 6, 329–333 (2006).
Bettelli, E. et al. Reciprocal developmental pathways for the generation of pathogenic effector Th17 and regulatory cells. Nature 441, 235–238 (2006).
Staudt, V. et al. Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 33, 192–202 (2010).
Chang, H.C. et al. The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat. Immunol. 11, 527–534 (2010).
Mosmann, T.R. & Coffman, R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7, 145–173 (1989).
Watts, T.H. TNF/TNFR family members in costimulation of T cell responses. Annu. Rev. Immunol. 23, 23–68 (2005).
Croft, M. Control of immunity by the TNFR-related molecule OX40 (CD134). Annu. Rev. Immunol. 28, 57–78 (2010).
Vu, M.D. et al. OX40 costimulation turns off Foxp3+ Tregs. Blood 110, 2501–2510 (2007).
Piconese, S., Valzasina, B. & Colombo, M.P. OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection. J. Exp. Med. 205, 825–839 (2008).
Demirci, G. & Li, X.C. Novel roles of OX40 in the allograft response. Curr. Opin. Organ Transplant. 13, 26–30 (2008).
Ito, T. et al. TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J. Exp. Med. 202, 1213–1223 (2005).
Rogers, P.R., Song, J., Gramaglia, I., Killeen, N. & Croft, M. OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells. Immunity 15, 445–455 (2001).
Vu, M.D. et al. Critical, but conditional, role of OX40 in memory T cell-mediated rejection. J. Immunol. 176, 1394–1401 (2006).
Murata, K. et al. Constitutive OX40/OX40 ligand interaction induces autoimmune-like diseases. J. Immunol. 169, 4628–4636 (2002).
Sugamura, K., Ishii, N. & Weinberg, A.D. Therapeutic targeting of the effector T cell costimulatory molecule OX40. Nat. Rev. Immunol. 4, 420–431 (2004).
Perumal, N.B. & Kaplan, M.H. Regulation of IL-9 transcription in T helper cells. Trends Immunol. 32, 146–150 (2011).
Xiao, X. et al. New insights on OX40 in the control of T cell immunity and immune tolerance in vivo. J. Immunol. 188, 892–901 (2012).
Noelle, R.J. & Nowak, E.C. Cellular sources and immune functions of interleukin-9. Nat. Rev. Immunol. 10, 683–687 (2010).
Vallabhapurapu, S. & Karin, M. Regulation and function of NF-κB transcription factors in the immune system. Annu. Rev. Immunol. 27, 693–733 (2009).
Zhou, P. et al. Transplantation tolerance in NF-κB-impaired mice is not due to regulation but is prevented by transgenic expression of Bcl-xL. J. Immunol. 174, 3447–3453 (2005).
Zhan, Y. et al. Glucocorticoid-induced TNF receptor expression by T cells is reciprocally regulated by NF-κB and NFAT. J. Immunol. 181, 5405–5413 (2008).
Franzoso, G. et al. Mice deficient in nuclear factor (NF)-κB/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture. J. Exp. Med. 187, 147–159 (1998).
Lo, J.C. et al. Coordination between NF-κB family members p50 and p52 is essential for mediating LTbR signals in the development and organization of secondary lymphoid tissues. Blood 107, 1048–1055 (2006).
Hildebrand, J.M. et al. Roles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functions. Immunol. Rev. 244, 55–74 (2011).
Paul, P.K. et al. The E3 ubiquitin ligase TRAF6 intercedes in starvation-induced skeletal muscle atrophy through multiple mechanisms. Mol. Cell. Biol. 32, 1248–1259 (2012).
King, C.G. et al. TRAF6 is a T cell-intrinsic negative regulator required for the maintenance of immune homeostasis. Nat. Med. 12, 1088–1092 (2006).
Murray, S.E. et al. NF-κB–inducing kinase plays an essential T cell–intrinsic role in graft-versus-host disease and lethal autoimmunity in mice. J. Clin. Invest. 121, 4775–4786 (2011).
Temann, U.A., Geba, G.P., Rankin, J.A. & Flavell, R.A. Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness. J. Exp. Med. 188, 1307–1320 (1998).
Veldhoen, M. et al. Transforming growth factor-β 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat. Immunol. 9, 1341–1346 (2008).
Dardalhon, V. et al. Interleukin 4 inhibits TGF-β-induced-Foxp3+ T cells and generates, in combination with TGF-β, Foxp3− effector T cells that produce interleukins 9 and 10. Nat. Immunol. 9, 1347–1355 (2008).
Nowak, E.C. et al. IL-9 as a mediator of Th17-driven inflammatory disease. J. Exp. Med. 206, 1653–1660 (2009).
Schmitt, E. et al. IL-9 production of naive CD4+ T cells depends on IL-2, is synergistically enhanced by a combination of TGF-β and IL-4, and is inhibited by IFN-γ. J. Immunol. 153, 3989–3996 (1994).
Tan, C. & Gery, I. The unique features of Th9 cells and their products. Crit. Rev. Immunol. 32, 1–10 (2012).
Wilhelm, C. et al. An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation. Nat. Immunol. 12, 1071–1077 (2012).
Lu, L.F. et al. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 442, 997–1002 (2006).
Goswami, R. & Kaplan, M.H. A brief history of IL-9. J. Immunol. 186, 3283–3288 (2011).
Ito, T. et al. OX40 ligand shuts down IL-10-producing regulatory T cells. Proc. Natl. Acad. Sci. USA 103, 13138–13143 (2006).
Das, J. et al. Transforming growth factor β is dispensable for the molecular orchestration of Th17 cell differentiation. J. Exp. Med. 206, 2407–2416 (2009).
Jash, A. et al. Nuclear factor of activated T cells 1 (NFAT1)-induced permissive chromatin modification facilitates nuclear factor-κB (NF-κB)-mediated interleukin-9 (IL-9) transactivation. J. Biol. Chem. 287, 15445–15457 (2012).
Stassen, M. et al. IL-9 and IL-13 production by activated mast cells is strongly enhanced in the presence of lipopolysaccharide: NF-κB is decisively involved in the expression of IL-9. J. Immunol. 166, 4391–4398 (2001).
Kaur, D. & Brightling, C. OX40/OX40 ligand interactions in T cell regulation and asthma. Chest 141, 494–499 (2012).
Pippig, S.D. et al. Robust B cell immunity but impaired T cell proliferation in the absence of CD134 (OX40). J. Immunol. 163, 6520–6529 (1999).
Sato, T. et al. Consequences of OX40–OX40 ligand interactions in Langerhans cell function: enhanced contact hypersensitivity responses in OX40L-transgenic mice. Eur. J. Immunol. 32, 3326–3335 (2002).
Xiao, X. et al. OX40/OX40L costimulation affects induction of Foxp3+ regulatory T cells in part by expanding memory T cells in vivo. J. Immunol. 181, 3193–3201 (2008).
Hleb, M. et al. Evidence for cyclin D3 as a novel target of rapamycin in human T lymphocytes. J. Biol. Chem. 279, 31948–31955 (2004).
Maruyama, T. et al. Control of the differentiation of regulatory T cells and TH17 cells by the DNA-binding inhibitor Id3. Nat. Immunol. 12, 86–95 (2011).
Jember, A.G.-H., Zuberi, R., Liu, F.-T. & Croft, M. Development of allergic inflammation in a murine model of asthma is dependent on the costimulatory receptor OX40. J. Exp. Med. 193, 387–392 (2001).
Acknowledgements
We thank N. Ishii (Tohoku University) for OX40L-transgenic mice; A. McKenzie (MRC Laboratory of Molecular Biology) for IL-9-deficient mice; M. Alegre (University of Chicago) for IκBαΔN-transgenic mice; and D. Tenen (Harvard Medical School) for Sfp1f/f mice. Supported by the US National Institutes of Health and the Juvenile Diabetes Research Foundation International.
Author information
Authors and Affiliations
Contributions
X.X., S.B., W.L., X.C. and H.W. designed and did various experiments, E.J.T., Y.-X.F., Y.C. and M.C.W. provided reagents and animal models; and X.C.L. initiated the project, supervised the study and wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–4 (PDF 607 kb)
Rights and permissions
About this article
Cite this article
Xiao, X., Balasubramanian, S., Liu, W. et al. OX40 signaling favors the induction of TH9 cells and airway inflammation. Nat Immunol 13, 981–990 (2012). https://doi.org/10.1038/ni.2390
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni.2390
This article is cited by
-
The E3 ubiquitin ligase TRAF6 controls CTLA-4 turnover and promotes T-cell-mediated antitumor immunity
Cellular & Molecular Immunology (2023)
-
The OX40-TRAF6 axis promotes CTLA-4 degradation to augment antitumor CD8+ T-cell immunity
Cellular & Molecular Immunology (2023)
-
A NF-κB-Based High-Throughput Screening for Immune Adjuvants and Inhibitors
Inflammation (2023)
-
Dynamic chromatin accessibility licenses STAT5- and STAT6-dependent innate-like function of TH9 cells to promote allergic inflammation
Nature Immunology (2023)
-
Targeting ubiquitin signaling for cancer immunotherapy
Signal Transduction and Targeted Therapy (2021)